Polpharma SA - Company Profile

Powered by

All the data and insights you need on Polpharma SA in one report.

$ $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Polpharma SA Strategy Report

  • Understand Polpharma SA position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Polpharma SA: Overview

Select Item

Polpharma SA (Polpharma), a subsidiary Genefar BV, undertakes research activities, manufacturing, and marketing of prescription drugs, generic drugs, hospital drugs, dietary supplements, medical equipment, and over-the-counter medications. It provides drugs in therapeutic areas of cardiology, anti-infectives, gastroenterology, neurology, dermatology, pulmonary, and ophthalmology areas. The company also manufactures dietary supplements and medical devices. The company undertakes operations in Central and Eastern Europe, the Caucasus and Central Asia markets, and production plants in Russia, Kazakhstan, and Poland. Polpharma group includes Santo; Medana SA; Polfa Warszawa S.A; Zakłady Farmaceutyczne Polpharma SA; and Polpharma Biuro Handlowe. Polpharma is headquartered in Starogard, Poland.

 Gain a 360-degree view of Polpharma SA and make more informed decisions for your business Gain a 360-degree view of Polpharma SA and make more informed decisions for your business Find out more
Headquarters Poland
Address Pelplinska 19, Starogard, Pomeranian, 83-200
Website www.polpharma.pl
Telephone 48 58 5631600
No of Employees 4,324
Industry Pharmaceuticals and Healthcare
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Polpharma SA premium industry data and analytics

90+

Marketed Drugs

Understand Polpharma SA’s commercialized product portfolio to stay one step ahead of the market.

80+

Clinical Trials

Determine Polpharma SA go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

13+

Pipeline Drugs

Identify which of Polpharma SA’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

12+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Polpharma SA’s relevant decision makers and contact details.

7

Catalyst Calendar

Proactively evaluate Polpharma SA’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

1

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

1

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Polpharma SA (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

Products and Services

Products
Hospital Drugs
Prescription Drugs
Over-the-Counter (OTC) Products
XYZ
XYZ
XYZ
Understand Polpharma SA portfolio and identify potential areas for collaboration Understand Polpharma SA portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 Acquisitions/Mergers/Takeovers In March, the company merged with Polfa Warszawa.
2022 Contracts/Agreements In July, the company entered into an agreement with Pikralida to protect against the development of epilepsy after a traumatic brain injury or stroke.
2021 Financing Agreements In July, the company signed a loan agreement to invest PLN300 million for Research and Development activities.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Polpharma SA Bioton SA Adamed Pharma SA EVER Neuro Pharma GmbH Opocrin SpA
Headquarters Poland Poland Poland Austria Italy
City Starogard Warszawa Czosnow Unterach Modena
State/Province Pomeranian - Masovian Oberosterreich -
No. of Employees 4,324 358 2,700 1,000 -
Entity Type Private Public Private Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Executives
Name Position Board Since Age
Sebastian Szymanek President; Chairman; Vice President - Management Board of Zaklady Farmaceutyczne POLPHARMA SA Executive Board 2021 -
Andrzej Dziuban Member of the Management Board Senior Management 2019 -
Philip Fritzsche Member- Management Board Senior Management 2019 -
Wojciech Rosa Member - Management Board Senior Management 2017 -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Polpharma SA key executives to enhance your sales strategy Gain insight into Polpharma SA key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward